207 related articles for article (PubMed ID: 5720797)
1. Neoplastic properties of animal cell lines. Multiple-layered perfusion cultures.
Kruse PF
Natl Cancer Inst Monogr; 1968 Dec; 29():277-8. PubMed ID: 5720797
[No Abstract] [Full Text] [Related]
2. Evidence for oncogenic properties of primary cultures.
Defendi V
Natl Cancer Inst Monogr; 1968 Dec; 29():269-70. PubMed ID: 5720796
[No Abstract] [Full Text] [Related]
3. Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines.
Yerganian G; Nell MA; Cho SS; Hayford AH; Ho T
Natl Cancer Inst Monogr; 1968 Dec; 29():241-68. PubMed ID: 4306757
[No Abstract] [Full Text] [Related]
4. Evidence for oncogenic properties of heteroploidy cell lines.
Sanford KK
Natl Cancer Inst Monogr; 1968 Dec; 29():283-7. PubMed ID: 5720798
[No Abstract] [Full Text] [Related]
5. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties.
Foley GE
Natl Cancer Inst Monogr; 1968 Dec; 29():217-28. PubMed ID: 4888929
[No Abstract] [Full Text] [Related]
6. Identification standards of primary cultures and diploid cell lines--discussion.
Stulberg CS
Natl Cancer Inst Monogr; 1968 Dec; 29():15-9. PubMed ID: 5720789
[No Abstract] [Full Text] [Related]
7. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion.
Dawe CJ
Natl Cancer Inst Monogr; 1968 Dec; 29():229-32. PubMed ID: 5720795
[No Abstract] [Full Text] [Related]
8. Neoplastic properties of animal cell lines--general comments.
Macpherson I
Natl Cancer Inst Monogr; 1968 Dec; 29():295-6. PubMed ID: 4976360
[No Abstract] [Full Text] [Related]
9. Cell cultures for virus vaccine production. General conclusions from the conference.
Merchant DJ
Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
[No Abstract] [Full Text] [Related]
10. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Fellowes ON
Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794
[No Abstract] [Full Text] [Related]
11. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion.
Sandberg AA
Natl Cancer Inst Monogr; 1968 Dec; 29():233-6. PubMed ID: 5252583
[No Abstract] [Full Text] [Related]
12. Technology of production of primary and diploid cell cultures.
Brackett RG
Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
[No Abstract] [Full Text] [Related]
13. Vaccines produced in heteroploid cell lines--discussion.
Hull RN
Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
[No Abstract] [Full Text] [Related]
14. Characteristics of primary cultures and diploid cells--technology of production.
Holper JC
Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
[No Abstract] [Full Text] [Related]
15. Viral oncogenicity and viral vaccines--general comments.
Gerber P
Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
[No Abstract] [Full Text] [Related]
16. Karyologic characteristics of the WI-38 diploid cell system--general comments.
Rubin BA; Minecci LC; Tint H
Natl Cancer Inst Monogr; 1968 Dec; 29():97-104. PubMed ID: 5720816
[No Abstract] [Full Text] [Related]
17. Evidence for oncogenic properties of heteroploid cell lines--discussion.
Moore AE
Natl Cancer Inst Monogr; 1968 Dec; 29():291-2. PubMed ID: 4890060
[No Abstract] [Full Text] [Related]
18. Vaccines produced in diploid cell lines--discussion.
Perkins FT
Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
[No Abstract] [Full Text] [Related]
19. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Jensen KE
Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
[No Abstract] [Full Text] [Related]
20. Clinical experience with vaccines produced in the human diploid cell line WI-38.
Andzaparidze OG
Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
